Friday, 10 July 2020

8:00 AM - 9:00 AM

Virtual (New York time)

---

Side Event

---

Documentation

• A call to Action: Vaccine Literacy: Building Public Support for a COVID-19 vaccine | WP1791
• Concept Note and Agenda: COVID-19 vaccines: scientific advances, access models and vaccination acceptance

UN Technology Facilitation Mechanism, UN Department of Economic and Social Affairs, the World Health Organization, City University of New York Graduate School of Public Health and Health Policy, USCIB Foundation, Business Partners for Sustainable Development, Wilton Park, and Gavi the Vaccine Alliance.

The event aims to feature scientific and research advances in COVID-19 vaccines, discuss access models and approaches for vaccine literacy and vaccine acceptance.

Experts will address the following questions:

1. What is the status of scientific research advances in COVID-19 vaccines? What are the implications for policy?
2. What are the most promising models for universal access? What are the most needed high priority actions in this regard?
3. How can public trust in science be earned, vaccine literacy be built, and misleading vaccine information and vaccine hesitancy be addressed?

Several co-organizers will also launch ‘CONVINCE’ (COVID New Vaccine Information, Communication and Education) – a call to action.

Registration

To attend the virtual event, please register here https://bit.ly/31zWmUQ .

Introduction and welcome by TFM 10-Member Group

1. Dr. Vaughan Turekian, Co-chair of TFM 10-Member Group; and Executive Director of Policy and Global Affairs, The National Academies of Sciences, Engineering, and Medicine, USA

Opening:

1. Mr. Liu Zhenmin, United Nations Under-Secretary-General for Economic and Social Affairs
2. Dr. Mariângela Batista Galvão Simão, Assistant Director-General, Access to Medicines and Health Products, World Health Organization

Moderator:

1. Mr. Richard A Roehrl, Senior Economic Affairs Officer, UN Department of Economic and Social Affairs

Experts:

1. Dr. Melanie Saville, Director of Vaccine Research & Development, Coalition for Epidemic Preparedness Innovations (CEPI)
2. Dr. Soumya Swaminathan, Chief Scientist, World Health Organization
3. Ms Aurélia Nguyen, Managing Director, Vaccines and Sustainability Department, GAVI – The Vaccines Alliance
4. Dr. Scott Ratzan, Distinguished Lecturer, City University of New York (CUNY) Graduate School of Public Health and Health Policy; and Executive Director for Business Partners for Sustainable Development
5. Prof. Heidi Larson, Professor of Anthropology, Risk and Decision Science and Director, The Vaccine Confidence Project, London School of Hygiene and Tropical Medicine
6. Ms. Nancy Lee, Programme Director, Global Health, Wilton Park, UK

Statements, questions and discussion

1. TFM 10-Member Group
1. Dr. Paulo Gadelha, TFM 10-Member Group, and former President, Fundação Oswaldo Cruz (Fiocruz), Brazil
2. Dr. Michiharu Nakamura, TFM 10-Member Group, and Counselor to the President, Japan Science and Technology Agency
3. Dr. Jose-Ramon Lopez-Portillo, TFM 10-Member Group, Mexico
2. Member States (tbc)
3. Stakeholders (tbc)
4. Selected questions submitted online
5. Responses by speakers

Closing

1. Mr. Shantanu Mukherjee, Chief, Integrated Policy Analysis Branch, DSDG, Department of Economic and Social Affairs